In 2015, Thailand health officials saw 142,925 reported dengue fever cases, with 141 fatalities. This included the death of Thai actor, Thrisadee “Por” Sahawong. Health officials at the time predicted...

An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to results published Thursday in The Lancet. The vaccine is the first to prevent infection...

Inovio Pharmaceuticals, Inc. today announced its DNA-based Zika vaccine (GLS-5700) generated robust antigen-specific antibody responses in a first-in-man, multi-center phase I trial. In initial testing,...

The number of mumps cases in Washington state has eclipsed the 100 mark as health officials put the tally at 107 as of Tuesday. King County accounts for 86 percent of cases (93) and the number reported...

The study, led by the London School of Hygiene & Tropical Medicine with Public Health England, found that the fall in visits was biggest among young children (the age group that receives the rotavirus...

Researchers from The University of Texas Medical Branch at Galveston have developed a vaccine against salmonella poisoning designed to be taken by mouth. The findings are detailed in an article published...

Researchers from The University of Texas Medical Branch at Galveston have developed the first vaccine for chikungunya fever made from an insect-specific virus that doesn’t have any effect on people,...

Last week, Gaithersburg, MD based biopharmaceutical company, Emergent BioSolutions Inc. announced the signing of a nearly $1 billion contract with the Centers for Disease Control and Prevention (CDC)...

Lyon, France biotech firm, Valneva SE, announced Friday  that its vaccine candidate VLA15 against Lyme disease is now progressing into clinical testing (Phase I) following the Investigational New Drug...

Two New York State universities are experiencing mumps outbreaks: The State University of New York (SUNY) at New Paltz and SUNY Geneseo, and student health at each school provided outbreak updates as...